Ron Martell - Feb 2, 2023 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role
President, CEO & Director, Director
Signature
/s/ Ronald A. Martell
Stock symbol
JSPR
Transactions as of
Feb 2, 2023
Transactions value $
$0
Form type
4
Date filed
2/3/2023, 03:13 PM
Previous filing
Oct 13, 2022
Next filing
Mar 20, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JSPR Stock Option (right to buy) Award $0 +1.09M $0.00 1.09M Feb 2, 2023 Voting Common Stock 1.09M $1.78 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares subject to the option shall vest on February 2, 2024, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.